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Abstract
Background: The gut-brain axis and the intestinal microbiota are emerging as key players in health and disease.
Shifts in intestinal microbiota composition affect a variety of systems; however, evidence of their direct impact on
cognitive functions is still lacking. We tested whether faecal microbiota transplant (FMT) from aged donor mice into
young adult recipients altered the hippocampus, an area of the central nervous system (CNS) known to be affected
by the ageing process and related functions.
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Results: Young adult mice were transplanted with the microbiota from either aged or age-matched donor mice.
Following transplantation, characterization of the microbiotas and metabolomics profiles along with a battery of
cognitive and behavioural tests were performed. Label-free quantitative proteomics was employed to monitor protein
expression in the hippocampus of the recipients. We report that FMT from aged donors led to impaired spatial
learning and memory in young adult recipients, whereas anxiety, explorative behaviour and locomotor activity
remained unaffected. This was paralleled by altered expression of proteins involved in synaptic plasticity and
neurotransmission in the hippocampus. Also, a strong reduction of bacteria associated with short-chain fatty acids
(SCFAs) production (Lachnospiraceae, Faecalibaculum, and Ruminococcaceae) and disorders of the CNS (Prevotellaceae
and Ruminococcaceae) was observed. Finally, the detrimental effect of FMT from aged donors on the CNS was
confirmed by the observation that microglia cells of the hippocampus fimbria, acquired an ageing-like phenotype; on
the contrary, gut permeability and levels of systemic and local (hippocampus) cytokines were not affected.
Conclusion: These results demonstrate that age-associated shifts of the microbiota have an impact on protein
expression and key functions of the CNS. Furthermore, these results highlight the paramount importance of the gut-
brain axis in ageing and provide a strong rationale to devise therapies aiming to restore a young-like microbiota to
improve cognitive functions and the declining quality of life in the elderly.
Background
Ageing leads to the loss of functional capacity in several
body systems, including the cardiovascular, skeletomus-
cular, osteoarticular and neuro-immune-endocrine, and
is often associated with a decline in psychological well-
being and cognitive function. In the past few years, it
has been brought to the surface that events taking place
in the gut play an important role in the ageing process
[1], and recently, the existence of bidirectional commu-
nication between the gut and the brain—the gut-brain
axis—has emerged as an important player in shaping as-
pects of behaviour and cognitive function [2]. In par-
ticular, the gut microbiome has been reported to play
an important role within this scenario. A modest alter-
ation in the composition of the gut microbiota, induced
by either diet or antibiotics, is sufficient to cause
changes in mouse brain chemistry and function [3, 4].
In particular, the oral administration of antibiotics re-
sulted in an increase in brain-derived neurotrophic fac-
tor (BDNF) in the hippocampus. Furthermore, reduced
expression of the synaptic plasticity-related genes PSD-
95 and synaptophysin, important in memory formation
and maintenance, were also reported [5]. Yet, germ-free
(GF) mice are less responsive to exposure of environ-
mental stressors compared to conventionally reared
mice, with conventionalization of GF animals impacting
significantly on brain development [6]. This observa-
tion, along with a growing body of evidence, has shown
that the gut microbiota plays a major role in in the de-
velopment and function of the CNS, affecting learning
and memory via metabolic, neuroendocrine and im-
mune pathways [7]. In addition, dysbiosis has been asso-
ciated with a variety of neurological disturbances
ranging from depression [8] to autism [9, 10], along
with neurodegenerative diseases such as Parkinson’s
disease and multiple sclerosis [11, 12]. Not surprisingly,
faecal microbiota transplant (FMT) is being investigated
as a therapeutic option not only for GI-tract-related dis-
eases [13], but also for CNS disorders [14, 15]. Thus, it
is plausible to hypothesize that age-associated changes
in the microbiota composition have a direct effect on
the CNS, potentially contributing to the decline of cog-
nitive function seen in the elderly. Recently, it has been
reported that FMT from aged donor mice into young
germ-free (GF) recipients increased hippocampal neuro-
genesis, intestinal growth and activation of the prolon-
gevity signalling pathways in the liver [16]; however, up
to date, the direct impact of the ageing microbiota on
cognitive functioning and activity has not been ad-
dressed. We report that FMT from aged mice led to a
decline of spatial learning and memory in young adult
(henceforth termed adult) recipients via modulation of
synaptic plasticity- and neurotransmission-related pro-
teins in the hippocampus, an area of the CNS known to
be heavily affected by the ageing process [17]. The im-
pact of age-associated shifts of microbiota on the CNS
was further confirmed by the observation that microglia
cells of the hippocampus fimbria of adult mice acquired
an ageing-like phenotype after FMT from aged donors.
These changes occurred in the absence of an overt in-
crease of both plasma and hippocampal levels of inflam-
matory cytokines and intestinal permeability.
Results
Microbiota of adult recipients acquires an aged
phenotype following FMT from aged donors
We investigated in the first instance the faecal microbiotas
of adult (3months) and aged mice (24months) (Fig. 1).
Measures of alpha diversity showed only a significant (P =
0.0107) difference in species richness between the two
D’Amato et al. Microbiome           (2020) 8:140 Page 2 of 19
cohorts, with the faecal microbiota of aged mice harbour-
ing more different amplicon sequence variants (ASVs)
than adult mice (Fig. 1a). Beta diversity (Bray-Curtis) ana-
lysis showed clear separation of the two groups of mice
based on their faecal microbiotas (Fig. 1b). Comparison of
relative abundances of different taxa showed significantly
more ASVs associated with Ruminiclostridium, Butyrici-
coccus, Lachnoclostridium, Lachnospiraceae spp., Shuttle-
worthia and Marvinbryantia, and significantly fewer
associated with Staphylococcus, Jeotgalicoccus, Facklamia,
Parvibacter, Enterorhabdus, Muribaculum, Parabacter-
oides and Anaerostipes in the adult mice relative to the
aged mice (Fig. 1c). Integration of faecal microbiomic and
metabolomic data showed an association between lower
levels of faecal short-chain fatty acids (SCFAs) (Fig. 2) and
decreased representation of obligate anaerobes such as the
Lachnospiraceae and Ruminococcaceae (Fig. 3). The above
approach was paralleled by the metabolomics analysis of
the intestinal luminal contents. Using 1H-NMR to profile
luminal metabolites, we were able to obtain insights into
microbiota metabolism and function that can only be
inferred from metagenomics or transcriptomics ap-
proaches. Using Principal Component Analysis to com-
pare and contrast 89 metabolites (including amino acids,
organic acids, sugars, nucleosides and short-chain fatty
acids), clear separations of the metabolic profile detected
in conventionalized adult and aged mice were apparent
(PC1) (Additional file 1). Based on this analysis, faeces
from three of the adults and two of the aged mice repre-
sentative of the two groups were pooled and used as do-
nors for FMT (Additional file 1). To this end, it is
important to stress that many studies have employed
germ-free animals to determine the role of the gut micro-
biota in modulating aspects of host physiology, but this
approach is however not suitable for our purposes. Germ-
free mice bear significant abnormalities in BBB structure
and integrity [18] and in microglial numbers and morph-
ology [19] profoundly complicating interpretation of the
effects of FMT in our model. We have therefore chosen to
use antibiotic-mediated microbial depletion to examine
the mediating role of the gut microbiota, as while removal
of gut microbes may not be as comprehensive as in germ-
Fig. 1 Comparison of the faecal microbiotas of adult and aged mice. a Measures of alpha diversity. Significance of differences between the two
groups was assessed by Wilcoxon rank sum test. b MDS plot of a Bray-Curtis assessment of beta diversity. Data presented are for ASVs present in
more than two animals and prevalence threshold of 1% at the genus level. c Comparison of the relative abundance of different genera present in
the faecal microbiota of the two cohorts. Purple text, significantly different (Welch’s t test and Wilcoxon; P < 0.05, Benjamini-Hochberg) based on
ALDEx2 analyses
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free animals, we have avoided the confounding effects
caused by development in an entirely microbe-free envir-
onment. Adult mice received FMT either from adult do-
nors (FMT-adult) or aged donors (FMT-aged). Groups of
transplanted mice were then used to assess the post-FMT
microbiota profile. Measures of alpha diversity showed no
significant differences between the two mouse sub-groups
(Fig. 4a). Bray-Curtis analysis showed clear separation of
the pre- and post-FMT groups, with the post-FMT sam-
ples clustering with their respective inoculants (Fig. 4b). It
is notable that antibiotic treatment of pre-FMT mouse 1
(Ms1) and mouse 2 (Ms2) was not completely successful
as they clustered more closely with the post-FMT adult
group and adult pooled sample. However, after these mice
had been inoculated with the adult pooled sample, they
clustered with the aged post-FMT group. The differences
in the faecal microbiotas between the adult and aged mice
post-FMT were not as pronounced as the differences seen
between the adult and aged groups in our initial study; as
such a less stringent Benjamini-Hochberg cut-off (P < 0.1)
was used when analysing these data (Fig. 1). This less-
pronounced change is unsurprising as the adult and aged
mice in the initial study had not been subject to any inter-
vention; however, it is becoming clear that even subtle
changes in the gut microbiome are associated with pheno-
typic changes in the host [20] and the same may be true of
cognitive traits. Only four genera (Prevotellaceae, Faecali-
baculum, Lachnospiraceae and Ruminococcaceae) were
found to be significantly differentially abundant in the fae-
ces of the post-FMT adult and post-FMT aged animals
(Fig. 4c). Few significant associations were seen between
the faecal microbiomic and metabolomic data (Fig. 4d).
FMT from aged mice to adult recipients results in
decreased spatial learning and memory but does not
affect anxiety-like behaviour or motor activity
In the first set of experiments, we investigated the im-
pact of FMT from aged mice to adult recipients to a
series of spatial learning and memory tests. First, the
Barnes maze test was used to assess memory and spatial
Fig. 2 Pearson correlation of faecal microbiomic and metabolomic data for adult and aged mice. ALDEx2 was used to correlate the datasets. +, P
< 0.05 (Benjamini-Hochberg). Only rows/columns containing significant data are shown. (8 mice/group)
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learning. Following the training trials, a retention test
was conducted in which the escape tunnel was removed
and the latency before moving to the position of the
former escape tunnel for the first time was measured.
We observed that the average primary latency was sig-
nificantly higher for FMT-adult recipients of microbiota
from aged donors (FMT-aged) than the other control
groups either left untreated or colonized with microbiota
from adult, age-matched donors (FMT-adult) (41.7 ±
3.5 s; 30.5 ± 3.9 s and 23.5 ± 6.7 s, respectively; P < 0.05)
(Fig. 5a). Yet, during the retention test, FMT-aged mice
spent less time in the target quadrant (28.9 ± 2.6 s in
comparison to control 46.5 ± 6.3 s, and FMT-adult 51.8
± 10.2 s; P < 0.05) that contained the escape tunnel com-
pared to control group (Fig. 5b; heat map in Fig. 5c)
confirming an important role of the gut microbiota on
memory and spatial learning. Learning and memory was
further evaluated by the novel object recognition test.
Significant differences between groups were observed in
the time spent exploring two different objects (Fig. 5d).
In particular, the time spent exploring novel and familiar
objects was monitored; the object recognition was
assessed by a defined discrimination index. Control
groups, either untreated or FMT-adult mice, preferred
the novel object more than the familiar one, whereas
FMT-aged mice showed a significant reduction in the
time spent exploring the novel object compared to con-
trol (0.23 ± 0.04 and 0.46 ± 0.05, respectively; P < 0.01)
suggesting reduced discrimination as a consequence of
impaired memory capabilities. This is further evidenced
by the heat maps (Fig. 5e).
Given that the microbiota has been reported to affect
locomotor activity and anxiety-like behaviour in animal
models [5, 21], we then assessed whether FMT from
aged animals to adult recipients could also affect these
behavioural manifestations. For this purpose, we
employed two validated tests: the open field and the ele-
vated plus maze. In the open field task, no significant
difference in the distance travelled by both FMT-aged
and FMT-adult was observed when compared to the un-
treated control group indicating no significant motor
impairments of the animals (Fig. 6a). However, it is
Fig. 3 Pearson correlation of faecal microbiomic and metabolomic data for adult and aged mice. ALDEx2 was used to correlate the datasets. +, P
< 0.05 (Benjamini-Hochberg). All data are shown (8 mice/group)
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worth noting that FMT-aged mice displayed a tendency
to prefer the periphery or the corners of the arena in-
stead of the centre (Fig. 6b). The representative tracks of
movement patterns are depicted in Fig. 6c–e (ANY-
maze software). In the elevated plus maze, FMT-aged
mice did not display significant differences in time spent
in either arms of the maze compared to control groups
(Fig. 6f–g) with most of the animals spending the major-
ity of the time in the closed arms irrespective of the
FMT treatment.
FMT from aged donors alters protein expression in the
hippocampus of adult recipients
The observation that FMT from aged donors to adult re-
cipients could alter behavioural patterns of transplanted
mice prompted us to investigate the molecular mecha-
nisms underlying such changes. To this extent, a one-
shot label-free quantitative proteomics approach was
employed, targeting the hippocampus, a brain region
known to play an important role in learning and mem-
ory and to undergo several changes with the advancing
Fig. 4 Effect of FMT on the faecal microbiotas of adult mice. a Measures of alpha diversity among the pooled adult (n = 1) and aged (n = 1)
samples, the adult mice pre FMT (n = 11) and the adult mice after FMT with adult (n = 4) and aged (n = 7) faeces. b MDS plot of a Bray-Curtis
assessment of beta diversity. Data presented are for ASVs present in more than two animals and prevalence threshold of 1% at the genus level. c
Box plots for the genera that were significantly different (Welch’s t test and Wilcoxon; P < 0.1, Benjamini-Hochberg) between post FMT adult (n =
4) and post FMT aged (n = 7) mice based on ALDEx2 analyses. d Pearson correlation of faecal microbiomic and metabolomic data. Only rows/
columns that contained significant data (P < 0.1, Benjamini-Hochberg) are shown
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of age [22]. The analyses resulted in the quantitation of
2180 protein groups and 16,083 unique peptides (Add-
itional file 2). The Pearson correlation coefficients be-
tween samples and technical replicates were 0.99,
indicating a high reproducibility and confidence of the
resulting data (Additional file 3 a). The volcano plot was
obtained by two-sided t test of the two groups: FMT
aged faeces into adult mice related to the adult FMT
into adult mice (Additional file 3 b). One hundred forty
proteins were differentially regulated, 52 overexpressed
and 88 down-expressed, of which 47 proteins were dif-
ferentially regulated with a fold change higher than 1.5
(Table 1). Furthermore, western blot analyses of two
selected proteins implicated in the behavioural pheno-
type of transplanted mice, the microtubule-associated
protein MAPT (FMT-aged versus FMT-adult ratio: 2.38)
(Additional File 4) and tRNA-splicing ligase RtcB homo-
log Rtcb (FMT-aged versus FMT-adult of 0.46) (Add-
itional File 5) confirmed the patterns identified by the
label-free proteomics approach.
Subsequent protein network analyses highlighted sev-
eral differentially expressed proteins in the hippocampus
of adult mice that received microbiota from aged donors
compared to adult mice that received microbiota from
age-matched adult donors. Table 1 summarizes the main
enriched categories. Cellular signalling during nervous
Fig. 5 Effect of FMT from adult and old mice on spatial learning and memory. Barnes maze test (Fig. 3a–c): mice were trained to find the cage
for 4 consecutive days (twice daily; 2 trials). The average primary latency (Fig. 3a) was significantly higher for adult recipients of microbiota from
aged donors (FMT-aged) than the other control groups either left untreated or colonized with microbiota from adult, age-matched donors (FMT-
adult). Furthermore, during the retention test, FMT-aged mice spent less time in the target quadrant that contained the escape tunnel compared
to control groups (Fig. 3b; heat map in Fig. 3c). The values represent the mean ± SEM for each group (n = 10–12 mice/group). *P < 0.05 vs
control animals and FMT-adult. The novel object recognition test (Fig. 3d–e): on day 1, mice were exposed to two similar objects (A + A); on day
2, animals were re-exposed to the testing area containing one novel object (A + B). The time spent by the animals exploring each object was
recorded. The discrimination index, calculated as (TB-TA)/(TB + TA), was used to assess the preference for the novel object. Control groups, either
untreated or FMT-adult mice, preferred the novel object more than the familiar one, whereas FMT-aged mice showed a significant reduction in
the time spent exploring the novel object (heat map in 3e) suggesting reduced discrimination as a consequence of impaired memory
capabilities. The values represent the mean ± SEM for each group (n = 10–12 mice/group). **P < 0.01 vs control animals
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system development and related to synaptic transmission
was described by 35 molecules, differentially expressed,
indicating a downregulation during the transplant (z-
score − 1.7). Neurotransmission was also found down-
regulated by 41 differentially expressed molecules.
Remarkably the changes in the expression of a total of
87 learning-related proteins and cognition tests in FMT-
aged mice pointed to a decline of brain functions as seen
during the physiological ageing process (Fig. 7). Original
data for the cognition and behaviour tests can be found
in Additional file 6. As a corollary, the extent of the ef-
fects of the shifts of microbiota on health and disease in
ageing is further stressed by the observation that a large
set of proteins involved in lipid metabolism were down-
regulated (Additional file 7). This latter evidence sug-
gested that shifts of microbiota might underpin the
detrimental effects of ageing on multiple health-critical
functions. Thus, the single label-free run approach resulted
in an in-depth hippocampus protein characterization and
above all in the identification of differentially regulated pro-
teins involved in key pathways of ageing-related processes.
Integration of microbiomic and proteomic data revealed
few significant associations (Fig. 8). In particular, Faecaliba-
culum, Lachnospiraceae and Ruminococcaceae were found
to be significantly correlated with proteins implicated in
mitochondrial energy metabolism (electron transport chain,
complex 1 biogenesis, oxidative phosphorylation), but also
neurotransmitter transport (Fig. 8).
Furthermore, integration of metabolomic and prote-
omic data showed a significant association between five
of the 67 metabolites and any of the 1648 hippocampal
proteins (Benjamini-Hochberg (BH); P value < 0.05). In
particular, “Guanosine derivate” was significantly corre-
lated with 256 proteins (Additional file 8), “Arabinose”
Fig. 6 Effect of FMT from adult and old mice on locomotor and explorative activity and anxiety-related behaviour. Open field test did not show
significant difference in the distance travelled by both FMT-aged and FMT-adult was observed when compared to the untreated control group
indicating no significant motor impairments of the animals (Fig. 4a). However, FMT-aged mice displayed a tendency to prefer the periphery or
the corners of the arena instead of the centre (Fig. 4b). The representative tracks of movement patterns are depicted in Fig. 4c–e (ANY-maze
software). Furthermore, in the elevated plus maze, FMT-aged mice did not display significant differences in time spent in either arms of the maze
compared to control groups (Fig. 4f, g). The values represent the mean ± SEM for each group (n = 10–12 mice/group)
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was significantly correlated with 312 proteins (Additional
file 9), and “Fatty acids C6-onwards” was significantly cor-
related with 148 proteins (Additional file 10). “Glycolate”
was only significantly anti-correlated with haemoglobin
subunit beta-1 (r − 0.94, BH P value 0.031). “4-Hydroxy-
phenyl compound” was only significantly correlated with
alpha-aminoadipic semialdehyde dehydrogenase (r 0.94,
BH P value 0.025) (Additional file 11).
FMT from aged donors into adult recipients triggers
phenotypic changes in glia cells of the hippocampus
fimbria but did not affect gut permeability or levels of
systemic and brain cytokines
It has been suggested that FMT from aged donors trig-
gers systemic inflammageing in adult recipients [23].
Consequently, we investigated whether FMT from aged
donors triggered increased systemic levels of pro-
inflammatory cytokines and intestinal permeability in
adult recipients. We report that neither gut permeability
(Fig. 9a) nor plasma levels of inflammatory cytokines
(Fig. 9b) changed following FMT. Furthermore, levels of
a large panel of cytokines were also evaluated in protein
extracts from the hippocampi of FMT-treated groups
(Additional file 12); similarly to what we observed at the
systemic level, we did not detect a difference between
any of the cytokine tested demonstrating the absence of
FMT-triggered neuroinflammation, at least at this time
point post-FMT. Also, we observed in specific regions of
the hippocampus (Additional file 13) that FMT from
aged donors did not induce increase in glial fibrillary
acidic protein (GFAP) expression in astrocytes of hippo-
campus regions (Fig. 10a–h) further confirming the lack
of an overt neuroinflammatory response. On the other
hand, a significant (P = 0.0168) increase in the expres-
sion of F4/80, a typical trait of the ageing brain [24], was
observed in glia cells in the white matter of the hippo-
campus fimbria (Fig. 10j–l). The expression of both
GFAP and F4/80 was further confirmed by western blot
(Additional file 14 and Additional file 15, respectively).
Discussion
The decline of cognitive and behavioural functions in
ageing is one of the most detrimental effects of ageing
[25]. In particular, a deficit of hippocampal-dependent
functions, including spatial learning and memory, is a
distinctive trait of ageing [17]. Although the role of the
gastrointestinal tract and gut microbiome on the devel-
opment and function of the CNS has become evident in
the past few years [2, 5, 3, 4, 6], the extent of the impact
of the age-associated shits of the gut microbiota on
Table 1 Ingenuity pathway analysis (IPA)
Functions
annotation
P
value
Activation
z-score
Molecules #
molecules
Cell-to-cell signalling and Interaction,
nervous system development and
function
Synaptic
transmission
2.83E
−11
− 1.763 AMPH, ANKS1B, CAMK2A, CNP, CPNE6, DLG2, DLG4,
DPYSL2, ERC2, FBXO2, GNAI2, HNRNPK, MAPT, NAPA,
NPTX1, NRCAM, NSF, PAFAH1B1, PARK7, PPP3CA,
PPP3R1, PRKCG, PSMC5, RAB3A, S100B, H3GL2, SLC12A5,
SLC1A3, SNAP25, SNPH, SYN1, SYN2, SYNGAP1, UNC13A,
VDAC1
35
Behaviour Learning 2.72E
−14
− 1.697 ACTG1, AMPH, ATP1A3, CAMK2A, CFL1, CKB, CKMT1A/
CKMT1B, CPT1C, CRMP1, CTNND2, DLG3, DLG4, ELAVL4,
FBXO2, GMFB, GSK3B, HAPLN1, KCNAB2, MAPT, NCAM1,
NCDN, NRAS, NRCAM, NTRK2, PAFAH1B1, PARK7, PDE1B,
PEX5L, PPP3CA, PPP3R1, PRKAR1A, PRKAR2B, PRKCG,
RTN4, S100B, SHANK1, SLC12A5, SNAP25, SOD2, SRCIN1,
SYNGAP1, SYNJ1, SYNPO, TRIM3, TSN, VDAC1
46
Cell-to-cell signalling and interaction,
nervous system development and
function
Neurotransmission 4.44E
−12
− 1.656 AMPH, ANKS1B, CAMK2A, CNP, CPNE6, DLG2, DLG4,
DNM1, DPYSL2, ERC2, FBXO2, GDAP1, GNAI2, HNRNPK,
KCTD12, MAPT, NAPA, Nefm, NPTX1, NRCAM, NSF,
NTRK2, PAFAH1B1, PARK7, PPP3CA, PPP3R1, PRKCG,
PSMC5, RAB3A, S100B, SH3GL2, SLC12A5, SLC1A3,
SNAP25, SNPH, SRCIN1, SYN1, SYN2, SYNGAP1, UNC13A,
VDAC1
41
Cell morphology, cellular assembly
and organization, nervous system
development and function
Elongation of
neurites
4.27E
−08
− 0.228 ALCAM, CAMK2A, DPYSL2, GNAS, MAPT, NTRK2, OMG,
PACSIN1, PAFAH1B1, PFN1, PFN2, RAB35
12
Behaviour Locomotion 6.83E
−07
− 0.087 ABAT, AGAP2, ATP1A1, ATP1A3, CAMK2A, CNP, DLG3,
DLG4, DNM1, ELAVL4, GMFB, HINT1, MAPT, NCAM1,
NEFL, NRCAM, NTRK2, OMG, OXR1, PAFAH1B1, PARK7,
PDE1B, RTN4, SNAP25, SOD1, SOD2, SPTBN4, TSN
28
Ingenuity pathway analysis (IPA) of the significantly up- and downregulated proteins (after Bonferroni correction) in the hippocampus of young mice transplanted
with faeces from aged donors (FMT-aged) versus young mice transplanted with faeces transplant from young age-matched mice (FMT-adult). The enriched
categories, related to specific function annotations, the P value, the z-score of the software and the involved proteins are displayed
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specific functions of the CNS remained to be deter-
mined. Here we report that FMT from aged donors af-
fects memory and spatial learning in transplanted adult
mice, a phenomenon led through a differential expres-
sion of proteins involved in maintenance of synaptic
plasticity and neurotransmission in the hippocampus
area. These findings demonstrated that the transfer of an
aged-like microbiota into young mice is sufficient to
evoke similar memory and cognitive alterations to that
found in aged mice and in so doing ultimately strength-
ening the role of the intestinal microbiota on key func-
tions of the CNS. Indeed, although the short-term
working memory is similar in young and aged mice, the
latter exhibit significant deficits in spatial memory
Fig. 7 Ingenuity pathway analysis (IPA). IPA of the significantly up- and downregulated proteins (after Bonferroni correction) for faeces from aged
donors transplanted in adult mice versus faeces from adult donors transplanted in adult age-matched mice, in the hippocampus tissue. The
circles represent the main network node and the blue colour the significantly downregulated nodes. The upregulated proteins are marked red,
while those that that were downregulated are marked in green. The intensity of the colour relates to fold-change (light to dark colour = small to
large fold change). The symbols shown in the network are explained
at http://www.qiagenbioinformatics.com/products/ingenuity-pathway-analysis
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compared to young mice [26–31]. Similarly, the novel
object recognition memory has been reported to decay
with ageing [32–35]. Also, previous works showed in-
creased anxiety-like behaviours associated to cognitive
impairments in middle-aged and aged mice [36, 37],
which could be prevented by prebiotic supplementation
[37]. By contrast, we reported that other deficits trig-
gered by the ageing process, such as locomotor activity
and anxiety-like behaviour [38, 30], were not affected by
the FMT procedure suggesting that age-associated shifts
of microbiota tend to have a more selective impact on
cognition and memory in mice.
Although the presence of specific microbial families
and genera have been associated with cognitive decline,
anxiety behaviours and affective disorders [39], to our
knowledge, this is the first evidence showing that FMT
significantly affects important cognitive functions of the
CNS in ageing. Such observations prompted us to inves-
tigate the potential underlying mechanisms and whether
the observed changes in cognition and behaviour may be
triggered through the modification of proteins relevant
for CNS function.
A label-free quantitative proteomics approach showed
a significant modification of protein expression in the
hippocampus area. In particular, the variation of the ex-
pression of proteins, such as D-dopachrome decarboxyl-
ase (D-DT), neuronal membrane glycoprotein M6-a
(Gmp6A) and M6-b and Ras/Rap GTPase-activating
protein SynGAP, was of significance. Indeed, alterations
in the expression of these proteins in the CNS have been
implicated in important CNS functions and distur-
bances, ranging from filopodium formation, synaptogen-
esis, learning disability, behavioural anomalies and
neuronal plasticity to neurodegenerative disorders [40].
Fig. 8 Pearson correlation of faecal microbiomic and proteomic (hippocampus) data. Only rows/columns that contained significant data (P < 0.1,
Benjamini-Hochberg) are shown
D’Amato et al. Microbiome           (2020) 8:140 Page 11 of 19
Although the major pathways affected by the FMT
procedures pertained to synaptic transmission, learning
and neurotransmission (Table 1), the label-free quantita-
tive approach suggested that it is plausible that FMT
from aged donors might mimic the effects of physio-
logical ageing on other CNS structures and functions.
For instance, although major alterations of the blood-
brain barrier (BBB) components were not detected, we
observed a downregulation of proteins involved in glu-
cose transport across the BBB such as SlcA1 and A3
[41] following FMT from aged donors (Additional file 1)
that might contribute to the dysfunctional bioenergetic
system of the ageing brain [42]. Interestingly, integration
of microbiomics and proteomics data revealed significant
interactions with proteins involved in energy metabol-
ism. Impaired brain glucose metabolism is known to
compromise transmembrane ion transport, vesicle recyc-
ling and synaptic signalling [43, 44].
In addition to these observations, it has been suggested
that changes in the microbiota are associated with
increased gut permeability and systemic inflammation
that may play an important role in age-associated alter-
ation, of cognitive and behaviours in ageing [45]. With
regard to inflammation, it has been described that FMT
from aged donors to young germ-free recipients trig-
gered systemic inflammageing including enhanced CD4+
T cell differentiation and distribution of several Th1 and
Treg subsets, in particular in the systemic compartment
[23]. However, the latter report fell short of measuring
circulating pro-inflammatory cytokines and cognitive/be-
havioural functions in the recipients. In our experiments,
a small non-significant increase was observed for IL-1β
and TNF-α. More importantly, we failed to detect any
increase of regulatory cytokines, either pro- or anti-
inflammatory in the hippocampi of FMT-treated mice.
Also, consistent with the lack of a significant inflamma-
tory response is our observation that levels of GFAP did
not increase in various areas of the hippocampus. How-
ever, currently, we cannot rule out a direct effect of pro-
inflammatory cytokines on protein expression and
Fig. 9 FMT from aged donors does not affect either gut permeability or circulating cytokines. Mice were orally administered with a solution of
FITC-dextran and plasma levels measured after 180 min. No differences were observed between FMT-adult and FMT-aged recipients. Plasma
samples were also used to evaluate levels of circulating cytokines; also in this case we failed to observe any significant change of circulating pro-
and anti-inflammatory cytokines in both group of FMT-treated mice (n = 8 mice/group)
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function. Indeed, cytokine levels were assessed at the
end of the intervention period and we do not know
whether fluctuations of cytokine levels occurred at
the early-stage post-FMT, thus rendering cytokine de-
tection unlikely. This possibility still makes it plaus-
ible to hypothesize that the changes in the CNS
observed here might be linked to a microbiota-
associated increase, albeit minor inflammation, both
locally and systemically.
Mice that received FMT from aged donors showed
phenotypic change of the microglia, resident immuno-
competent cells in the CNS [46] that monitor and regu-
late specific neuronal elements including synapses and
neuronal cell bodies and in so doing they play an active
role in neuronal surveillance in homeostatic conditions
as well as in response to disease and injury. Indeed, simi-
larly to what observed during physiological ageing [24],
we observed a significant increase in the expression of
Fig. 10 Post-FMT levels of GFAP and F4/80 in hippocampal areas. Representative images acquired at the confocal microscope with anti-GFAP
antibody (green) and the relevant fluorescent intensity in different areas of the hippocampus (a–h). No difference was observed between FMT-
adult (left panels a, d and g) and FMT-aged (middle panels b, e and h) in the expression of GFAP. The analysis was carried out in the dentate
gyrus region (a, b, fluorescent intensity shown in c), CA4 region (d, e, fluorescent intensity shown in f) and CA3 region (g–I, fluorescent intensity
shown in i). By contrast, a significant increase of the expression of F4/80 (red) (j, k, fluorescent intensity shown in l) was observed in the white
matter of the hippocampus fimbria between FMT-adult (j) and FMT-aged mice (k). The detail of the hippocampus regions investigated are
displayed in Additional File 13. Fluorescence intensity bars represent the mean ± SEM from 3 mice/group and asterisk indicates P = 0.0168. Nuclei
have been counterstained with ToPro-3 (in blue). (scale bars 30 μm)
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the marker F4/80 in microglia cells of the hippocampus
fimbria. Whether this phenotypic change of the microglia
contributed to the changes observed in the hippocampus
of mice following the FMT from aged donors remains to
be determined. Indeed, the F4/80, an established macro-
phage marker, is a member of the epidermal growth factor
(EGF)-transmembrane 7 (TM7) family, and although its
increased expression has been linked to the induction of
oral tolerance, its function remains unknown [47]
Furthermore, integration of faecal microbiomic and
metabolomic data showed a clear association between
lower levels of SCFAs and decreased representation of
obligate anaerobes such as the Lachnospiraceae and
Ruminococcaceae that have been associated with the
production of SCFAs by the human faecal microbiota
(Figs. 2. and 3). It should, however, be noted the bio-
logical relevance of increased levels of faecal propionate,
butyrate and isobutyrate being significantly correlated
with increased relative abundance of lactic acid bacteria
such as Staphylococcus, Jeotgalicoccus and Facklamia is
currently unknown (Figs. 2. and 3) as our knowledge as
to the ability of these species to produce SCFAs other
than acetate or lactate from fermentation of carbohy-
drate or protein sources is poor as is our knowledge on
cross-feeding potential of the mouse gut microbiota.
In addition to these aforementioned genera, a strong de-
crease in Prevotellaceae was also observed following FMT
from aged donors in adult recipients. We previously reported
higher levels of Prevotellaceae and Ruminococcaceae in
APOE3/E3 and APOE2/E3 genotype carriers, respectively,
relative to APOE4 carriers [48], one of the strongest preva-
lent risk factors for neuropathology and Alzheimer’s disease
[49]. While the under-representation of Prevotellaceae has
been previously reported to diminish the levels of health-
promoting neuroactive SCFAs in humans [50] and the bio-
synthesis of thiamine and folate, two vitamins decreased in
Parkinson’s disease [51, 52], depletion of Ruminococcaceae
has been associated with Alzheimer’s disease [53]. Interest-
ingly, a previous study showed that SCFAs may regulate host
serotonin biosynthesis [54], a multifaceted neurotransmitter
modulating cognition, learning and memory, along with nu-
merous physiological processes [55]. Finally, the role of the
vagus nerve on microbiota-mediated alterations of the
hippocampus area cannot be ruled out. This cranial nerve
exerts an important role in gut-brain communication [56],
and it has been shown that it mediates the effects of orally
delivered probiotic strains on aspects of behaviour [57]. Fu-
ture experiments of selective vagotomy will help to elucidate
the role of the vagus nerve in the microbiota-mediated de-
cline of spatial and learning memory.
Conclusion
Overall, these results further highlight the paramount
importance of events taking place in the GI-tract in
health and disease and stressed the paramount import-
ance of the intestinal microbiota on the gut-brain axis.
In particular, these demonstrated a direct impact of age-
associated shifts of the intestinal microbiota composition
on CNS-specific pathways that led to a significant de-
cline of key functions, such as spatial learning and mem-
ory. This notion, along with the recently collected
evidence that correcting age-associated shift of micro-
biota profile is beneficial for health and life expectancy
[58]. Indeed, it provides a solid support to the hypothesis
that microbe-based approaches that aim to restore a
young-like microbiota might improve cognitive function
and in so doing the quality of life of the elderly, an ever-
increasing demographic segment of modern societies.
Methods
Animals
Adult (3months) and aged (24months) male C57BL/6
mice were used. Mice (Envigo, Varese, Italy or Charles
River, UK) were provided with food and water ad libitum.
Environmental temperature was kept at 23 ± 1 °C with a
12-h light/dark cycle. All efforts were made to minimize
animal suffering and to reduce the number of mice used.
Faecal material preparation and FMT regime
Faecal material was collected from adult and aged mice
and placed into Eppendorf tubes containing 500 mL of
freezing solution (sterile saline solution with 12.5% gly-
cerol) and homogenized. The suspended pellets were
then stored at − 80 °C until utilized. For FMT, mice were
randomized into the following groups (n = 12 per
group): control (no antibiotic treatment, no FMT),
FMT-adult (antibiotic treatment followed by FMT from
adult age-matched donors) and FMT-aged (antibiotic
treatments followed by FMT from aged donors). Anti-
biotic mix was administered by oral gavage. The anti-
biotic/anti-fungal regime (Additional file 16) was as
follows: day 1–3 mice were gavaged daily with anti-
fungal treatment with amphotericin B 1mg kg-1, day 4–
17 mice received a daily gavage of metronidazole 100
mg kg-1 while the antibiotic mix (ampicillin 1 g L-1,
vancomycin 0.5 g L-1 and neomicin 1 g L-1 was added to
drinking water), day 18-24 daily oral gavage with ampi-
cillin 1 g L-1, vancomycin 0.5 g L-1, neomicin 1 g L-1,
metronidazole 100mg kg-1, amphotericin B mg kg-1.
FMT was carried out via oral gavage with a faecal sus-
pension (100 mgmL-1) in a final volume of 150 mL.
FMT was performed six times on days 24–28 and 35
from the beginning of antibiotic regime.
DNA extraction, amplicon sequencing and analyses of 16S
rRNA gene sequence data and metabolomics analysis
Pre- and post-FMT faecal material was used for micro-
biota profiling. DNA was extracted from faecal samples
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using the FastDNA SPIN Kit for Soil (MP Biomedicals)
with three bead-beating periods of 1 min as previously
described [59]. DNA concentration was normalized to 1
ng/μL by dilution with DNA elution solution (MP Bio-
medicals, UK) to produce a final volume of 20 μL. Nor-
malized DNA samples were sent to the Earlham
Institute (Norwich, UK) for PCR amplification of 16S
rRNA genes and paired-end Illumina sequencing (2 ×
250 bp) on the MiSeq platform. The V4 hypervariable
region of the 16S rRNA genes was amplified using the
515F and 806R primers with built-in degeneracy as pre-
viously reported [60, 61]. Sequence data were provided
in fastq format. All processing and analyses were done
in R/Bioconductor making use of the following packages:
GEOquery 2.50.0 [62], dada2 1.10.0 [63], phyloseq 1.26.0
[64], tidyverse 1.2.1 (https://www.tidyverse.org), vegan
2.5.3, viridis 0.5.1, msa 1.14.0 [65], phangorn 2.4.0,
ALDEx2 1.14.0 [59] and gplots 3.0.1. Taxonomy was
assigned to chimera-free Exact Sequence Variants [66]
using Silva 132 (downloaded from https://zenodo.org/
record/1172783#.W-B0iS2cZBw on 5 November 2018).
Data were filtered to remove undefined phyla and taxa
present in fewer than two animals. Significance of differ-
ences between different diversity measures was deter-
mined using Wilcoxon rank sum test. ALDEx2 was used
to determine statistically significant differences (Welch’s
t test, Wilcoxon) between mouse groups. The 16S rRNA
gene sequence data have been deposited in the NCBI
BioProject database (https://www.ncbi.nlm.nih.gov/bio-
project/) under accession number PRJNA524024.
Metabolites were analysed and quantified by 1H-NMR
analysis as previously described [67]. Briefly, 20 mg of
frozen faeces was thoroughly mixed on a vortex with 1
mL of saline phosphate buffer followed by centrifugation
(18,000 g, 1 min). High-resolution 1H-NMR spectra were
recorded on a 600-MHz Bruker Avance spectrometer fit-
ted with a 5-mm TCI proton-optimized triple resonance
NMR “inverse” cryoprobe and a 60-slot autosampler
(Bruker, Rheinstetten, Germany). Metabolites were iden-
tified using information found in the literature or on the
Human Metabolome Database, http://www.hmdb.ca/
and by use of the 2D-NMR methods, (e.g. COSY, HSQC
and HMBC [68]) and quantified using the software Che-
nomx® NMR Suite 7.0TM.
Behavioural tests
The tests were performed following the order of descrip-
tion and between 08:00 am and 03:00 pm. Barnes Maze
test: this test was conducted according to previously de-
scribed method [69]. All sessions were performed on a
wet platform under a room lightning of 400 lux to in-
crease the mouse aversion for the platform. Sessions
were recorded using a video-tracking system (ANY-
maze, Ugo Basile, Varese, Italy). The platform and the
escape box were cleaned thoroughly between each
mouse session and the surface of the platform was
moistened again to avoid mice using olfactory cues to
solve the task. Before performing the test, mice were
trained to find the cage for 4 days with 2 sessions per
day. Open field test (OFT) was conducted as previously
described [70]. Briefly, mice were placed in the centre of
the OFT and the total distance the mice travelled along
with the time they spent in the centre of the field within
5 min was recorded with a video tracking system. The
open field maze was cleaned between each mouse with
20% ethanol to eliminate odour. Novel object recogni-
tion test was carried out as previously described [71].
For each mouse, the time spent interacting with each ob-
ject during the acquisition and recognition phases was
video recorded and analysed blind. The corrected mnesic
index (or discrimination index) was calculated as follows:
(time spent exploring the novel object − time spent ex-
ploring the well-known object)/total time spent exploring
both the objects. To evaluate anxiety-related behaviour,
the elevated plus-maze test was conducted as previously
described [38]. Time spent in each kind of arms (s) was re-
corded for 5min. Percentage of entries into the open arms
and that of time spent in the open arms were determined.
Data acquisition and analysis were performed automatic-
ally using ANY-maze software.
Liquid chromatography-MS analysis
Each sample was analysed by nLC MS/MS Orbitrap Fu-
sion trihybrid mass spectrometer coupled with a nano
flow UHPLC system (Thermo Fischer Scientific, USA),
via a nano electrospray source with an ID 0.01 mm fused
silica PicoTip emitter (New Objective). The peptides
were separated, after trapped on a C18 pre-column,
using a gradient of 3–40% acetonitrile in 0.1% formic
acid, over 50 min at flow rate of 300 nL/min, at 40 °C.
The MS method consisted of a full scan in Orbitrap ana-
lyser (120,000 resolution), followed by the combination
of CID and HCD collisions. The peptides were fragmen-
ted in the linear ion trap by a data-dependent acquisition
method, selecting the 40 most intense ions. Dynamic ex-
clusion of sequenced peptides was set to 30 s. Data were
acquired using Xcalibur software (Thermo Scientific,
USA). All analyses were performed in triplicate. MS raw
data were analysed by MaxQuant (version 1.6.2.3), using
Andromeda search engine in MaxQuant and consulting
the Homo Sapiens UniProtKB database; the tolerance on
parents was 10 ppm and on fragments was 0.02 ppm.
The variable modifications allowed were oxidation on
methionine and acetylation on N terminus and carba-
midomethylation on cysteine as fixed modification. The
false discovery rate was below 1%, using a decoy and re-
verse database, and a minimum number of seven amino
acids were required for peptide identification. Proteins
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and protein isoforms were grouped into protein groups.
Label-free quantitative analyses were also performed by
MaxQuant software, using the MaxLFQ algorithm. The
quantitation values were obtained on high-resolution
three-dimensional peptide profiles in mass-to-charge, re-
tention time and intensity space. The mass spectrometry
proteomics data have been deposited to the ProteomeX-
change Consortium via the PRIDE [72] partner reposi-
tory with the dataset identifier PXD016432.
Intestinal permeability and plasma cytokines
Plasma levels of cytokines were assessed by enzyme-
linked immunosorbent assays (ELISA). Assays were car-
ried out according to the manufacturer’s instructions (all
kits from eBioscience). Also, the level of cytokines was
determined in protein extracts from hippocampi of
FMT-treated mice using Procarta Plex Analyst 1.0
(eBioscience) following instructions provided by the
manufacturer. Intestinal permeability was assessed using
a method described previously [73]. Animals were orally
delivered with 0.5 mL of PBS containing 25 mg of FITC-
labelled dextran (FD4; Sigma-Aldrich), and blood sam-
ples were collected after 45 min. Plasma concentration
of FD4 was assessed using fluorescence spectrometer
(LS 55 conducted with FL WinLab software, PerkinEl-
mer, USA) at an excitation wavelength of 490 nm and
emission wavelength of 520 nm.
Statistical analyses
Microbiome data (genus level) were correlated (Pearson)
with metabolomic and proteomic data using aldex.corr()
within the Bioconductor package ALDEx2 [59]. For the
MS study, all data were evaluated by Perseus statistical
software. The protein expression fold change variation be-
tween two groups was analysed by two sides t test, setting
FDR less than 0.015 and s0 of 0.1. The differentially
expressed proteins, with a significant ratio FMT-aged/
FMT-adult (P value < 0.05), were analysed by Ingenuity
Pathway Analyses (Qiagen), and only the differentially reg-
ulated pathway with a significant z-score, after Bonferroni
test, was considered. The symbols shown in the network
are explained at http://www.qiagenbioinformatics.com/
products/ingenuity-pathway-analysis. Behavioural mea-
surements were performed for each treatment in two dif-
ferent experiments (n = 10–12 mice/group). All
assessments were performed in blind of the treatment re-
ceived by the mouse groups. Results were expressed as
means ± S.E.M. and the analysis of variance was per-
formed by two-way ANOVA. A Bonferroni’s significant
difference procedure was used as post hoc comparison. P
values of less than 0.05 or 0.01 were considered signifi-
cant. Data were analysed using the “Origin 9” software
(OriginLab, Northampton, USA).
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s40168-020-00914-w.
Additional file 1. Selection of donors. We carried out metabolomics
analysis of the intestinal luminal contents aged (red) and young (green)
mice; germ-free mice were used here as control for the metabolomic
profile (blue). Using 1H-NMR to profile luminal metabolites we were able
to obtain insights into microbiota metabolism and function that can only
be inferred from metagenomics or transcriptomics approaches. Using
Principal Component Analysis to compare and contrast 89 metabolites
(including amino acids, organic acids, sugars, nucleosides, short chain
fatty acids, etc.) clear separations of the metabolic profile detected in
germ free (GF) and conventionalised adult and aged mice were apparent
(PC1). Of particular relevance was the finding that young and aged mice
housed under identical environmental conditions, were discriminated
(PC2), confirming age-related changes in the profile of intestinal micro-
biota in mice. The aged donors displayed a higher degree of heterogen-
eity compared to young mice. Two donors from the aged population
and three from the young cohort that were considered representative of
the two populations were selected (circles) and used as donors for FMT.
Additional file 2. List of protein evaluated by free-label proteomics.
Additional file 3. Post-FMT quantitative analysis of proteins in the
hippocampus. Volcano plot of quantified proteins in hippocampus tissue
(A). Differentially regulated proteins due to faeces from aged mice trans-
planted into adult mice (T) versus faeces from adult mice transplanted
into adult age-matched mice (C) are showed (T/C). The proteins in red
are up regulated and in green down regulated. Scatter Plot of protein in-
tensities (B) obtained by label free quantitation by MaxLFQ in MAxQuant,
showing the Person correlation coefficients between biological and tech-
nical replicates of analysed samples.
Additional file 4. Western Blot analysis for MAPT in the hippocampus of
FMT-treated mice. Polyacrylamide (12%) gel stained with blue Coomassie
with a representative image of molecular weight marker with relevant
kDa (a). GAPDH visualized bands and merged with nitrocellulose mem-
brane (b). Mapt visualized bands and merged with nitrocellulose mem-
brane (c). In (d) a representative histogram shows levels of analysed
protein both in FMT-Y and FMT-A treated and control animals. Lane 1
(positive control, SH-SY5Y cell line); lane 2 (negative control, H292 cell
line); lane 3 (aged mouse hippocampal proteins); lane 4 (adult mouse
hippocampal protein); lane 5 (FMT-aged hippocampal proteins); lane 6
(FMT-adult hippocampal proteins). Mapt protein was detected approxi-
mately at 50 kDa (right blots). GAPDH (37 kDa) was used as
housekeeping.
Additional file 5. Western Blot analysis for RTCB in the hippocampus of
FMT-treated mice. Polyacrylamide (12%) gel stained with blue Coomassie
with a representative image of molecular weight marker with relevant
kDa (a). GAPDH visualized bands (panel b, left) and merged with nitrocel-
lulose membrane (panel b, right). Rtcb visualized bands (panel c, left) and
merged with nitrocellulose membrane (panel c, right). In (d) representa-
tive histogram shows levels of analysed protein both in FMT-Y and FMT-
A treated and control animals. Lane 1 (positive control, SH-SY5Y cell line);
lane 2 (negative control, mouse adipose tissue); lane 3 (aged mouse hip-
pocampal proteins); lane 4 (adult mouse hippocampal protein); lane 5
(MT-aged hippocampal proteins); lane 6 (MT-adult hippocampal proteins).
Rtcb protein was detected approximately at 56 kDa (right blots). GAPDH
(37 kDa) was used as housekeeping (left panel). Molecular weight (mw)
used was SHARPMASS VII.
Additional file 6. Raw data for the cognitive and behavioural tests (XLS
file).
Additional file 7. Ingenuity pathway analysis (IPA). IPA analysis of the
significantly up- and down-regulated proteins (after Bonferroni analysis)
for faeces from aged donors transplanted in adult mice versus faeces
from adult donors transplanted into adult age-matched mice, in hippo-
campus tissue. The circles represent the main network node and the blue
colour the significantly down regulated. The up-regulated proteins are
marked in red, while those that that were down-regulated are marked in
green.
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Additional file 8. Metabolome-proteome correlation (Pearson). Results
for Guanosine derivate.
Additional file 9. Metabolome-proteome correlation (Pearson). Results
for Arabinose .
Additional file 10. Metabolome-proteome correlation (Pearson). Results
for Fatty acids C6 onwards .
Additional file 11. Metabolome-proteome correlation (Pearson) .
Additional file 12. Cytokine levels in the hippocampi.
Additional file 13. (Schematic of the regions of the hippocampus).
Schematic frontal section of a mouse hemibrain to show the regions
were confocal images were acquired to measure the GFAP and F4/80
fluorescence intensities. Images were taken from the dentate gyrus (DG),
and from the CA4 and CA3 regions of the hippocampal gyrus (GFAP
immunofluorescence) at -1.9 mm from the bregma. Images of the fimbria
(F4/80 immunofluorescence) were acquired at -1.4 mm from the bregma.
Lat ventr = lateral ventricule; cc = corpus callosum.
Additional file 14. GFAP western blotting. Polyacrylamide (10%) gel
stained with blue Coomassie with a representative image of molecular
weight marker with relevant kDa (a). GAPDH visualized bands and
merged with nitrocellulose membrane (b). GFAP visualized bands and
merged with nitrocellulose membrane (c). In (d) a representative
histogram shows levels of analysed protein both in FMT-Y and FMT-A
treated and control animals. Lane 1 (positive control, DITNC1 astrocyte-
derived cell line); lane 2 (negative control, BV-2 microglial cell line); lane 3
(aged mouse hippocampal proteins); lane 4 (adult mouse hippocampal
protein); lane 5 (MT-aged hippocampal proteins); lane 6 (MT-adult hippo-
campal proteins). GFAP protein was detected approximately at 55 kDa
(right blots). GAPDH (37 kDa) was used as housekeeping (left panel). Mo-
lecular weight (mw) used was SHARPMASS VII.
Additional file 15. F4/80 western blotting. Polyacrylamide (8%) gel
stained with blue Coomassie with a representative image of molecular
weight marker with relevant kDa (a). GAPDH visualized bands and
merged with nitrocellulose membrane (b). F4/80 visualized bands and
merged with nitrocellulose membrane (c). In (d) a representative
histogram shows levels of analysed protein both in FMT-Y and FMT-A
treated and control animals. Lane 1 (Negative control, RBE4 brain endo-
thelial cell line); lane 2 (positive control, BV-2 microglial cell line); lane 3
(aged mouse hippocampal proteins); lane 4 (adult mouse hippocampal
protein); lane 5 (MT-aged hippocampal proteins); lane 6 (MT-adult hippo-
campal proteins). F4/80 protein was detected approximately at 160 kDa
(right blots). αTubulin (52 kDa) was used as housekeeping (left panel). Mo-
lecular weight (mw) used was SHARPMASS VII.
Additional file 16. Summary of FMT procedure.
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